Botulinum toxin in upper limb spasticity after acquired brain injury: A randomized trial comparing dilution techniques

American Journal of Physical Medicine and Rehabilitation

Volumn 81, Issue 5, 2002, Pages 355-363

  Francisco, Gerard E ^a,b,c   Boake, Corwin ^a,b   Vaughn, Amy ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Institute for Rehabilitation and Research   (United States)

^c NONE   (United States)

Author keywords

Botulinum Toxin; Clinical Trial; Drug Therapy; Human; Muscle Spasticity; Randomized Controlled Trial

Indexed keywords

BRAIN; CHEMOTHERAPY; MUSCLE; ORTHOPEDICS;

DILUTION TECHNIQUES;

DISEASES;

BOTULINUM TOXIN;

ADULT; AGED; ARM DISEASE; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FINGER; FLEXOR MUSCLE; HUMAN; INTERMETHOD COMPARISON; MALE; SPASTICITY; WRIST;

ADULT; AGED; BOTULINUM TOXIN TYPE A; BRAIN INJURIES; CEREBROVASCULAR ACCIDENT; FEMALE; FINGERS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; WRIST;

EID: 0036117664     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200205000-00007     Document Type: Article

References (26)

1. Use of botulinum toxin in stroke patients with severe upper limb spasticity
2. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations
3. Management of spasticity in children with botulinum A toxin
4. Botulinum toxin A in the management of children with cerebral palsy
5. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients
6. Management of cerebral palsy with botulinum A toxin: Preliminary investigation
7. Botulinum toxin A in the treatment of spasticity: Functional implications and patient selection
8. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
9. Treatment of spasticity with botulinum toxin: A double blind study
10. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: An open-labeled trial
11. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients
12. Pharmacologic management of spasticity in adults with brain injury
13. Smoking, spasticity and pressure sores in spinal cord injured patients
14. Development of resistance to botulinum toxin type A in patients with torticollis
15. Botulinum antibodies in dystonic patients treated with type-A botulinum toxin: Frequency and significance
16. Spasticity: Etiology, evaluation, management, and the role of botulinum toxin type A
17. The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans
18. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients
19. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients
20. The effects of casting on upper extremity motor disorders after brain injury
21. Multimodality treatment of joint contractures in patients with severe brain injury
22. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis
23. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections
24. Interrater reliability of a modified Ashworth scale of muscle spasticity
25. Preliminary trial of carisoprodal in multiple sclerosis